Hurricane Helene: Recovery of Baxter's Manufacturing Operations in North Carolina

Hurricane Helene: Recovery of Baxter’s Manufacturing Operations in North Carolina

EXTRANEAL Peritoneal Dialysis Solution containing 7.5% Icodextrin

2,000 mL, NDC 0941-0707-03

Manufactured in Woodlands, Singapore

Important Prescribing Information

To be confirmed
Sodium Chloride 0.9% for Irrigation (UROMATIC) 3,000 mL, NDC 0338-0110-01

Produced in Thetford, UK

Important Prescribing Information

To be confirmed
Sterile Water for Injection USP 1,000 mL, NDC 0338-9782-01

Manufactured in Alliston, Canada

Important Prescribing Information

To be confirmed
70% Dextrose Injection USP 3,000 mL, NDC 0338-9789-01

Produced in Alliston Canada

Important Prescribing Information

To be confirmed
EXTRANEAL (icodextrin) Solution for Peritoneal Dialysis 2,500 mL, NDC 0941-0681-02

Manufactured in Castlebar, Ireland

Important Prescribing Information

Expected First Supply Date: late November 2024
DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 1.5% Dextrose 2,500 mL, NDC 0941-0684-01

Produced in Guangzhou, China

Important Prescribing Information

Expected First Supply Date: Late December 2024
DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose 2,500 mL, NDC 0941-0688-01

Produced in Guangzhou, China

Important Prescribing Information

Expected First Supply Date: Late December 2024
DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 4.25% Dextrose 2,500 mL, NDC 0941-0692-01

Produced in Guangzhou, China

Important Prescribing Information

Expected First Supply Date: Late December 2024
DIANEAL Low Calcium Peritoneal Dialysis Solution (Lactate-G 1.5%) 2,000 mL, NDC 0941-0686-01

Produced in Guangzhou, China

Important Prescribing Information

Expected First Supply Date: mid November 2024
DIANEAL Low Calcium Peritoneal Dialysis Solution (Lactate-G 2.5%) 2,000 mL, NDC 0941-0690-01

Produced in Guangzhou, China

Important Prescribing Information

Expected First Supply Date: mid November 2024
DIANEAL Low Calcium Peritoneal Dialysis Solution (Lactate-G 4.25%) 2,000 mL, NDC 0941-0694-01

Produced in Guangzhou, China

Important Prescribing Information

Expected First Supply Date: mid December 2024
0.9% Sodium Chloride Injection 250 mL, NDC 0338-9791-01

Manufactured in Shanghai, China

Important Prescribing Information

Expected First Supply Date: early December 2024
0.9% Sodium Chloride Injection 1,000 mL, NDC 0338-9793-01

Manufactured in Shanghai, China

Important Prescribing Information

Expected First Supply Date: late November 2024
5% Glucose Injection 250 mL, NDC 0338-9795-01

Manufactured in Shanghai, China

Important Prescribing Information

To be confirmed
5% Glucose Injection 1,000 mL, NDC 0338-9801-01

Manufactured in Shanghai, China

Important Prescribing Information

To be confirmed
10% Glucose Injection 250 mL, NDC 0338-9797-01

Manufactured in Shanghai, China

Important Prescribing Information

To be confirmed
5% Glucose and 0.9% Sodium Chloride Injection 1,000 mL, NDC 0338-9799-01

Manufactured in Shanghai, China

Important Prescribing Information

To be confirmed
50% Glucose Injection 3,000 mL, NDC 0338-9787-01

Produced in Thetford, UK

Important Prescribing Information

To be confirmed
70% Glucose Injection 500 mL, NDC 0338-9785-01

Produced in Thetford, UK

Important Prescribing Information

To be confirmed
0.9% Sodium Chloride Injection in VIAFLEX Plastic 250 mL, NDC 0338-9804-01

Manufactured in Shanghai, China

Important Prescribing Information

Expected First Supply Date: Early November 2024
0.9% Sodium Chloride Injection 500 mL, NDC 0338-9810-01

Manufactured in Shanghai, China

Important Prescribing Information

Expected First Supply Date: Early November 2024
0.9% Sodium Chloride Injection in VIAFLEX Plastic 1,000 mL, NDC 0338-9806-01

Manufactured in Shanghai, China

Important Prescribing Information

Expected First Supply Date: Early November 2024
0.9% Sodium Chloride Injection 500 mL, NDC 0338-9808-01

Manufactured in Shanghai, China

Important Prescribing Information

Expected First Supply Date: Late December 2024
DIANEAL PD4 Glucose 1.36% w/v / 13.6 mg/mL Solution for Peritoneal Dialysis 5,000 mL, NDC 0941-0484-03

Manufactured in Castlebar, Ireland

Important Prescribing Information

Expected First Supply Date: mid November 2024
DIANEAL PD4 Glucose 2.27% w/v / 22.7 mg/mL Solution for Peritoneal Dialysis 5,000 mL, NDC 0941-0487-05

Manufactured in Castlebar, Ireland

Important Prescribing Information

Expected First Supply Date: late November 2024
DIANEAL PD4 Glucose 3.86% w/v / 38.6 mg/mL Solution for Peritoneal Dialysis 5,000 mL, NDC 0941-0490-07

Manufactured in Castlebar, Ireland

Important Prescribing Information

Expected First Supply Date: late November 2024
DIANEAL PD-2 Peritoneal Dialysis Solution with 2.5% Dextrose 2,000 mL, NDC 0941-0698-01

Produced in Guangzhou, China

Important Prescribing Information

Expected First Supply Date: mid November 2024
DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 4.25% Dextrose 2,000 mL, NDC 0941-0696-01

Produced in Guangzhou, China

Important Prescribing Information

Expected First Supply Date: late November 2024
DIANEAL PD4 Glucose 2.27% w/v / 22.7 mg/mL Solution for Peritoneal Dialysis 2,500 mL, NDC 0941-0457-06

Manufactured in Castlebar, Ireland

Important Prescribing Information

Expected First Supply Date: early December 2024
DIANEAL PD-4 Low Calcium with 1.5% Dextrose 2,000 mL, NDC 0941-0711-01

Produced in Amata, Thailand

Important Prescribing Information

Expected First Supply Date: Early November 2024
DIANEAL PD-4 Low Calcium with 2.5% Dextrose 2,000 mL, NDC 0941-0713-01

Produced in Amata, Thailand

Important Prescribing Information

Expected First Supply Date: Early November 2024
DIANEAL PD-4 Low Calcium with 4.25% Dextrose 2,000 mL, NDC 0941-0715-01

Produced in Amata, Thailand

Important Prescribing Information

Expected First Supply Date: Late December 2024
DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 1.5% Dextrose 6,000 mL, NDC 0941-0701-01

Produced in Guangzhou, China

Important Prescribing Information

Expected First Supply Date: mid December 2024
DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose 6,000 mL, NDC 0941-0703-01

Produced in Guangzhou, China

Important Prescribing Information

Expected First Supply Date: mid December 2024
EXTRANEAL 7.5% w/v Icodextrin Peritoneal Dialysis Solution 2,500 mL, NDC 0941-0709-01

Produced in Alliston, Canada

Important Prescribing Information

To be confirmed
EXTRANEAL (icodextrin) Solution for Peritoneal Dialysis 2,000 mL, NDC 0941-0719-01

Manufactured in Castlebar, Ireland

Important Prescribing Information

Expected First Supply Date: early November 2024
EXTRANEAL (icodextrin) Solution for Peritoneal Dialysis 2,500 mL, NDC 0941-0681-02

Manufactured in Castlebar, Ireland

Important Prescribing Information

Expected First Supply Date: late November 2024
EXTRANEAL (icodextrin) Solution for Peritoneal Dialysis 2,000 mL, NDC 0941-0717-01

Manufactured in Castlebar, Ireland

Important Prescribing Information

Expected First Supply Date: early November 2024
EXTRANEAL (icodextrin) Solution for Peritoneal Dialysis 2,500 mL, NDC 0941-0681-01

Manufactured in Castlebar, Ireland

Important Prescribing Information

Expected First Supply Date: late November 2024
DIANEAL PD4 Glucose 1.36% w/v / 13.6 mg/mL Solution for Peritoneal Dialysis 2,500 mL, NDC 0941-0409-06

Manufactured in Castlebar, Ireland

Important Prescribing Information

Expected First Supply Date: early December 2024
DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 4.25% Dextrose 5,000 mL, NDC 0941-0705-01

Manufactured in Woodlands, Singapore

Important Prescribing Information

Expected First Supply Date: early December 2024
EXTRANEAL Peritoneal Dialysis Solution with 7.5% Icodextrin 2,000 mL, NDC 0941-0707-01

Produced in Woodlands, Singapore

Important Prescribing Information

Expected First Supply Date: mid November 2024
Plasma-Lyte 148 (pH 7.4) Solution for Infusion 1,000 mL, NDC 0338-9593-01

Manufactured in Sabinanigo, Spain

Important Prescribing Information

To be confirmed